Dyax Corp. (DYAX) Stock Analysis
DELISTED 2016
What happened to Dyax Corp. (DYAX) stock?
Dyax Corp. (DYAX) no longer trades on public markets. It was delisted in January 2016. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2016
- Last recorded price (historical):
- $38.41 (last quote on record before the January 2016 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Dyax Corp. (DYAX). Dyax Corp. was a biotechnology company focused on developing novel biotherapeutics, primarily utilizing its phage display technology platform. Its key asset, Kalbitor, was a treatment for hereditary angioedema (HAE) attacks, demonstrating clinical efficacy.
Last analyzed: Jun 15, 2026Dyax Corp. (DYAX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy DYAX shares?
No. DYAX stopped trading on public markets in January 2016, so the shares are not available through a broker. Anything you see quoted for DYAX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DYAX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Dyax Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.